Beigel, John H ;
Tomashek, Kay M ;
Dodd, Lori E...
Beigel , J H , Tomashek , K M , Dodd , L E , Mehta , A K , Zingman , B S , Kalil , A C , Hohmann , E , Chu , H Y , Luetkemeyer , A , Kline , S , Lopez de Castilla , D , Finberg , R W , Dierberg , K , Tapson , V , Hsieh , L , Patterson , T F , Paredes , R , Sweeney , D A , Short , W R , Touloumi , G , Lye , D C , Ohmagari , N , Oh , M-D , Ruiz-Palacios , G M , Benfield , T , Fätkenheuer , G , Kortepeter , M G , Atmar , R L , Creech , C B , Lundgren , J , Babiker , A G , Pett , S , Neaton , J D , Burgess , T H , Bonnett , T , Green , M , Makowski , M , Osinusi , A , Nayak , S , Lane , H C & ACTT-1 Study Group Members 2020 , ' Remdesivir for the Treatment of Covid-19 - Final Report ' , The New England Journal of Medicine , vol. 383 , no. 19 , pp. 1813-1826 . https://doi.org/10.1056/NEJMoa2007764.
,
2020
